vimarsana.com

Page 11 - மருத்துவ ப்ரிஸ்க்ரிப்ஶந் மருந்து திட்டங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centene To Present At Virtual JP Morgan 39th Healthcare Conference

Centene To Present At Virtual JP Morgan 39th Healthcare Conference News provided by Share this article Share this article ST. LOUIS, Dec. 31, 2020 /PRNewswire/  Centene Corporation (NYSE: CNC) announced today it will present at the virtual 39 th Annual J.P. Morgan Healthcare Conference, to be held January 11-14, 2021. Centene will participate in a virtual format on Monday, January 11 th at 9:10 a.m. Eastern Standard Time (EST). A simultaneous live audio webcast is available at: About Centene Corporation Centene Corporation, a Fortune 50 company, is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to nearly 1 i

Centene Corporation Announces 2021 Guidance

Press release content from PR Newswire. The AP news staff was not involved in its creation. Centene Corporation Announces 2021 Guidance December 18, 2020 GMT ST. LOUIS, Dec. 18, 2020 /PRNewswire/ Centene Corporation (NYSE: CNC) announced today its 2021 financial guidance. Total revenues are expected to be $114.1 billion to $116.1 billion, and diluted earnings per share are expected to be $3.82 to $4.06. Adjusted diluted earnings per share for 2021 are expected to be $5.00 to $5.30. For its 2021 fiscal year, the Company’s guidance is as follows: Total revenues in the range of approximately $114.1 billion to $116.1 billion. Diluted earnings per share of approximately $3.82 to $4.06. Adjusted diluted earnings per share of approximately $5.00 to $5.30.

Centene Signs Definitive Agreement to Acquire PANTHERx Rare Pharmacy (PANTHERx)

Centene Signs Definitive Agreement to Acquire PANTHERx Rare Pharmacy (PANTHERx) News provided by Share this article Share this article ST. LOUIS, Dec. 15, 2020 /PRNewswire/  Centene Corporation (NYSE: CNC) today announced it has signed a definitive agreement to acquire PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and rare diseases. The transaction is subject to regulatory approvals and is expected to close by the end of 2020. PANTHERx is a leader in rare disease pharmacy, comprehensively serving patients afflicted with rare and devastating conditions through delivery of medicine breakthroughs, clinical excellence, and access solutions. PANTHERx offers a suite of synchronized compliance, logistics, and analytics solutions to help streamline the process of delivering orphan medications and care to people living with complicated rare diseases.

WellCare, Crossroads Corporation and the Housing Partnership to Host COVID-19 Community Testing Event

Share this article Share this article CHARLOTTE, N.C., Dec. 11, 2020 /PRNewswire/  In response to Mecklenburg County s ongoing COVID-19 pandemic, WellCare is partnering with Crossroads Corporation, the Charlotte-Mecklenburg Housing Partnership, Grier Heights Community Center, and Power 98 FM to provide free COVID-19 testing and information on accessing resources in the community. Testing will take place during the Health for the Holidays Drive-Thru event on Sat., Dec. 12 from 2:00 p.m. to 5:00 p.m. at the Grier Heights Community Center located at 3100 Leroy Street in Charlotte.    During the event, StarMed Healthcare will offer screenings at no cost, including to those without health insurance. No appointments are needed but registration is strongly encouraged. Results will be available in 48 to 72 hours following testing.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.